Health experts are alarmed as Republicans degrade the country’s pivotal HIV programs — and break promises made during Trump’s ...
This story originally appeared in the Tuesday, Nov. 20, 2007 edition of the. Per California Education Code 59134, ...
Opportunistic infections target people with weakened immune systems, including those with HIV. These conditions can lead to ...
The search for long-COVID treatments echoes the previous struggles against HIV/AIDS. Now researchers are taking lessons from ...
Clinical Trials Arena on MSN
MSD’s once-daily HIV pill non-inferior to Biktarvy in Phase III trial
MSD announced the data just days after Gilead also touted success with a once-daily antiretroviral therapy (ART).
Today, Seema Sahay is Head of Division of Social Behavioural Research at the Indian Council of Medical Research, National Institute of Translational Virology & AIDS Research (NARI), Pune, India.
Merck said on Wednesday its experimental oral HIV medicine was found to be non-inferior to Gilead Sciences' top-selling drug ...
Eswatini has become the first African country to receive lenacapavir, a twice-yearly HIV prevention injection that global ...
AllAfrica on MSN
UNAIDS Warns of Rising HIV Infections Among Young Women, Calls for Urgent Action Ahead of World Aids Day
As the world prepares to mark World AIDS Day 2025, UNAIDS Country Director Jacqueline Makokha has warned that Uganda--and the global community is at a "critical juncture" in the fight against HIV, ...
Discover the inclusive health care services for New Jersey's LGBTQ community and the need for informed health professionals ...
About 1,000 doses of Gilead Sciences Inc's drug lenacapavir were delivered to Zambia and Eswatini last Thursday, U.S. and ...
New AI system helps scientists rapidly pinpoint the most promising paths to an HIV vaccine. view more . Credit: Scripps ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results